Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis

Molecular Medicine Reports

Volumn 2, Issue 1, 2009, Pages 73-80

  Takenaka, Kiyoshi ^a   Gemma, Akihiko ^a   Yoshimura, Akinobu ^a   Hosoya, Yoko ^a   Nara, Michiya ^a   Hosomi, Yukio ^a   Okano, Tetsuya ^a   Kunugi, Shinobu ^b   Koizumi, Kiyoshi ^a   Fukuda, Yuh ^b   Uematsu, Kazutsugu ^a   Shimizu, Kazuo ^a   Kudoh, Shoji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypermethylation; Idiopathic pulmonary fibrosis; Lung cancer; Smad4; Transforming growth factor

Indexed keywords

COMPLEMENTARY DNA; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DNA MICROARRAY; FIBROSING ALVEOLITIS; GENE ACTIVITY; GENE CONTROL; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; PROMOTER REGION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE MICROARRAY; TISSUE SECTION; TRANSCRIPTION REGULATION;

EID: 69249096597     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000064     Document Type: Article

References (28)

1. Panos RJ, Mortenson RL, Niccoli SA and King TE Jr: Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 88: 396-404, 1990. (Pubitemid 20147276)
2. Hubbard R, Venn A, Lewis S and Britton J: Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 61: 5-8, 2000. (Pubitemid 30055895)
3. Uematsu K, Yoshimura A, Gemma A, Mochimaru H, Hosoya Y, Kunugi S, Matsuda K, Seike M, Kurimoto F, Takenaka K, Koizumi K, Fukuda Y, Tanaka S, Chin K, Jablons DM and Kudoh S: Aberrations in the Fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis. Cancer Res 61: 8527-8532, 2001.
4. Gemma A, Hagiwara K, Ke Y, Burke LM, Kahn MA, Nagashima M, Bennett WP and Harris CC: FHIT mutations in human primary gastric cancer. Cancer Res 57: 1435-1437, 1997.
5. Gemma A, Takenaka K, Hosoya Y, Matuda K, Seike M, Kurimoto F, Ono Y, Uematsu K, Takeda Y, Hibino S, Yoshimura A, Shibuya M and Kudoh S: Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur J Cancer 37: 1554-1561, 2001. (Pubitemid 32744688)
6. Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y and Takenoshita S: Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res 60: 4507-4512, 2000. (Pubitemid 32103632)
7. Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte Waldhoff I, Maschek H and Schmiegel W: Mutations of the DPC/Smad4 gene in biliary tract carcinoma. Cancer Res 58: 1124-1126, 1998.
8. Bartsch D, Barth P, Bastian D, Ramaswamy A, Gerdes B, Chaloupka B, Deiss Y, Simon B and Schudy A: Higher frequency of DPC4/Smad4 alterations in primary pancreatic adenocarcinomas. Cancer Lett 139: 43-49, 1999.
9. Roth S, Laiho P, Salovaara R, Launonen V and Aaltonen LA: No Smad4 hypermethylation in colorectal cancer. Br J Cancer 83: 1015-1019, 2000.
10. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
11. Haddad R and Massaro D: Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med 45: 211-219, 1968.
12. Khalil N, O'Connor RN, Unruh P, Warren A, Kemp O, Bereznay K, Flanders KC and Green AH: Increased production and immunohistochemical localization of transforming growth factor-beta (TGF-β) in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5: 155-162, 1990.
13. Khalil N, O'Connor RN, Flanders KC and Unruh H: TGF-β, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study. Am J Respir Cell Mol Biol 14: 131-138, 1996.
14. De Caestecker MP, Piek E and Roberts AB: Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 92: 1388-1402, 2000. (Pubitemid 30696191)
15. Attisano L and Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 12: 235-243, 2000.
16. Massagué J and Wotton D: Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19: 1745-1754, 2000. (Pubitemid 30204386)
17. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, Da Costa LT, Rozenblum E, Weinstein CL, Fisher A, Yeo CJ, Hruban RH and Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353, 1996.
18. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA and Overhauser J: Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343-346, 1996. (Pubitemid 26230501)
19. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokawa K and Takahashi T: Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56: 2718-2720, 1996.
20. Schutte M, Hruban RM, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero RA Jr, Meltzer PS, Hahn SA and Kern SE: DPC4 gene in various tumor types. Cancer Res 56: 2527-2530, 1996.
21. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DR, Gnarra JR, Linehan WM and Baylin SB: Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704, 1994.
22. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MST1 in human cancers. Nat Med 1: 686-692, 1995.
23. Jones PL and Wolffe AP: Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol 9: 339-347, 1999. (Pubitemid 29532860)
24. Mori M, Kida H, Morishita H, Goya S, Matsuoka H, Arai T, Osaki T, Tachibana I, Yamamoto S, Sakatani M, Ito M, Ogura T and Hayashi S: Microsatellite instability in transforming growth factor-β1 type II receptor gene in alveolar lining epithelial cells of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 24: 398-404, 2001.
25. Parsons R, Myeroff L, Liu B, Wilson JKV, Markowitz S, Kinzler KW and Vogelstein B: Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550, 1995.
26. Takenoshita S, Hagiwara K, Gemma A, Nagashima M, Ryberg D, Lindstedt BA, Bennet WP, Haugen A and Haris CC: Absence of mutations in the transformation growth factor-β type II receptor in sporadic lung cancers with microsatellite instability and rare H-ras1 alleles. Carcinogenesis 18: 1427-1429, 1997. (Pubitemid 28134722)
27. Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K and Takahashi T: Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type-II expression caused by histone deacetylation in lung cancer cell lines. Cancer Res 61: 8331-8339, 2001.
28. Gold LI: The role of transforming growth factor-β (TGF-β) in human cancer. Crit Rev Oncog 10: 303-360, 1999.